D-0616-2026 Class II Ongoing

Recalled by Amgen, Inc. — Thousand Oaks, CA

FDA drug recall D-0616-2026 was initiated by Amgen, Inc. on Jun 4, 2026 and is designated Class II. Reason for recall: CGMP Deviations The recall status is ongoing.

Recall details

Product Type
Drugs
Report Date
Jul 1, 2026
Initiation Date
Jun 4, 2026
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Sensipar (cinacalcet) Tablets, 90mg, 30-count bottles, Rx Only, Distributed by: Amge, One Amgen Center Drive, Thousand Oaks, CA 91320-1799, Made in Japan. NDC 55513-075-30

Reason for recall

CGMP Deviations

Distribution pattern

Nationwide within the United States

Code information

Lot #: 1157056, Exp. Date 02/29/2028

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0616-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0616-2026. Report a data issue: hello@regdatalab.com.